FdaApplication
ANDA 217813
Identifiers
- fda_app_no: ANDA217813
Properties
| Property | Value |
|---|---|
| applicant_name | TRIS PHARMA INC |
| application_type | ANDA |
| approval_date | 2024-04-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEFLAZACORT | DEFLAZACORT | 22.75MG/ML | SUSPENSION;ORAL |
1 product